However, a recent study reported that a semiquantitative BCL2 IHC scoring system incorporating both proportion and intensity had strong independent prognostic power in patients with DLBCL treated with R-CHOP25. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.